Maverix Biomics
Maverix Biomics is dedicated to enabling researchers and healthcare providers with advanced Next Generation Sequencing (NGS) data analysis tools. Their mission is to deliver better science and healthcare advancements by providing validated, scientifically sound analysis pipelines and user-friendly tools that support a wide range of organisms. They support a variety of analyses for research and clinical diagnostics, aiming to eliminate bottlenecks and accelerate discovery and diagnostic results. Maverix offers solutions like MaverixWAVES™, MaverixDx™, and MaverixComplete™, and collaborates with leading institutions and companies to streamline genomic data analysis and interpretation.
Industries
Nr. of Employees
small (1-50)
Maverix Biomics
1875 South Grant Street, Suite 700, San Mateo, CA 94402
Products
Cloud-based genomic analytics platform
Web-accessible platform that hosts data, runs configurable NGS analysis pipelines, and provides interactive visualization and export of standard data formats.
End-to-end NGS workflow service
Coordinated service combining sample handling, library preparation, sequencing coordination, QC, and downstream analysis delivered on a cloud analytics platform.
Cloud-based genomic analytics platform
Web-accessible platform that hosts data, runs configurable NGS analysis pipelines, and provides interactive visualization and export of standard data formats.
End-to-end NGS workflow service
Coordinated service combining sample handling, library preparation, sequencing coordination, QC, and downstream analysis delivered on a cloud analytics platform.
Services
Cloud-hosted analysis of NGS data using validated pipelines, interactive visualizations, and delivery of analysis outputs and figures.
End-to-end project management covering sample handling, selection of library prep and sequencing depth, vendor coordination, QC, data transfer, and final analysis delivery on the analytics platform.
Integration of analysis workflows with clinical LIMS, provider portals, and features to support regulatory workflows and clinical report generation.
Cloud-hosted analysis of NGS data using validated pipelines, interactive visualizations, and delivery of analysis outputs and figures.
End-to-end project management covering sample handling, selection of library prep and sequencing depth, vendor coordination, QC, data transfer, and final analysis delivery on the analytics platform.
Integration of analysis workflows with clinical LIMS, provider portals, and features to support regulatory workflows and clinical report generation.
Expertise Areas
- NGS data analysis and pipeline development
- Transcriptomics and differential expression analysis
- Variant discovery and annotation
- Small RNA and exosome RNA analytics
Key Technologies
- Next-generation sequencing (NGS)
- RNA-seq (mRNA and small RNA)
- Whole-genome and exome sequencing
- Read alignment and BAM file generation
News & Updates
Diagnomics and Maverix Achieve CLIA Validation for Clinical Diagnostic Non-Invasive Prenatal Testing
Maverix and Diagnomics validated NGS-based prenatal testing for clinical diagnostics, enabling detection of fetal chromosomal abnormalities.
A grant program to support researchers in gene expression studies using RNA-Seq technology.
Announcement of a new RNA-Seq analysis kit by Maverix.
Introduction of the latest RNA-Seq analysis kit to improve gene expression studies.
Partnership with EDGC to utilize Maverix Dx platform for genetic analysis.
Diagnomics and Maverix Achieve CLIA Validation for Clinical Diagnostic Non-Invasive Prenatal Testing
Maverix and Diagnomics validated NGS-based prenatal testing for clinical diagnostics, enabling detection of fetal chromosomal abnormalities.
A grant program to support researchers in gene expression studies using RNA-Seq technology.
Announcement of a new RNA-Seq analysis kit by Maverix.
Introduction of the latest RNA-Seq analysis kit to improve gene expression studies.
Partnership with EDGC to utilize Maverix Dx platform for genetic analysis.